Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1765262011 | Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type (morphologic abnormality) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1773087011 | Therapy-related acute myeloid leukaemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1774373010 | Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1785804014 | Therapy-related AML and myelodysplastic syndrome, topoisomerase type II inhibitor-related type | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 30901000052111 | behandlingsrelaterad akut myeloisk leukemi och myelodysplastiskt syndrom, relaterat till topoisomerashämmare typ 2 | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type (morphologic abnormality) | Is a | Therapy-related acute myeloid leukemia and myelodysplastic syndrome | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor | Associated morphology | True | Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type (morphologic abnormality) | Inferred relationship | Some | 1 |
Reference Sets
Description inactivation indicator reference set
FHIR